CD36 is a critical receptor for regulating lipid metabolism in tumor microenvironment cells and promoting tumor growth and metastasis; therefore, CD36 may become a potential biomarker for clinical diagnosis/prognosis as well as a target for cancer therapy. This evidence concerns the gene CD36 and neoplasm.